Wells Fargo & Company Silo Pharma, Inc. Transaction History

Wells Fargo & Company

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$1.38 - $1.95 $4 - $5	-3 Reduced 15.0%	17 $0
Q4 2023 Feb 09, 2024	BUY	$1.3 - $1.84 $1 - $1	1 Added 5.26%	20 $0
Q3 2023 Nov 13, 2023	SELL	$1.67 - $2.3 $3 - $4	-2 Reduced 9.52%	19 $0
Q2 2023 Aug 15, 2023	BUY	$1.96 - $2.4 $1 - $2	1 Added 5.0%	21 $0
Q1 2023 May 12, 2023	BUY	$1.85 - $3.07 $1 - $3	1 Added 5.26%	20 $0
Q4 2022 Feb 13, 2023	BUY	$2.61 - $5.94 $49 - $112	19 New	19 $0

338K

Ticker SILO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 3,137,910
Market Cap $3.17M
Description
Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University ...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.